Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantationMauro Di Ianni(Azienda USL di Pescara)BloodFebruary 3, 201110.1182/blood-2010-10-311894Cited by 1,045SaveCiteExport RISWatch citationsRelated PapersDosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real‐world setting: Interim results of the Italian observational study (ROMEI)|Cancer|2025|10